CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on advancing ocular drug development by training early-stage researchers in preclinical research. It aims to address challenges in drug delivery and formulation for retinal diseases through collaboration among experts in various fields.
Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big pharma has entered recently.
Ocular drug development is a unique field in terms of drug targets and end-points of activity, local drug administration routes, tissue barriers and pharmacokinetics, drug delivery and formulation challenges and local toxicity issues.
These issues are slowing down the development of drugs for the unmet needs in ophthalmology.
Th…
UNIVERSITY OF EASTERN FINLAND (UEF)
ITA-SUOMEN YLIOPISTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom, Belfast
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Strasbourg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Eindhoven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
